Citius Oncology, Inc. CTOR Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s preferred stock, shares authorized?
- Citius Oncology, Inc. (CTOR) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Citius Oncology, Inc.'s preferred stock, shares authorized changed year-over-year?
- Citius Oncology, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Citius Oncology, Inc.'s preferred stock, shares authorized?
- Over 3 years (2022 to 2025), Citius Oncology, Inc.'s preferred stock, shares authorized has grown at a 115.4% compound annual growth rate (CAGR), from $1M to $10M.